Ozempic may reduce the mortality risk from colon cancer — GLP-1 users were less than half as likely to die within 5 years
🐦 **Trending on X: More Than Just Weight Loss!** Dr. Rhonda Patrick dropped some groundbreaking news, showing GLP-1s like Ozempic might slash colon cancer mortality risk by over 50%! This isn't just about the scale, folks; it's a powerful reminder of the deep, systemic health benefits these medications can offer for our long-term well-being.
Dr. Rhonda Patrick shared new research showing GLP-1 drugs (Ozempic, Wegovy, Mounjaro) may specifically target obesity-driven inflammatory pathways, reducing colon cancer mortality by more than 50%.
Related Articles
This GLP-1 transformation has the internet SHOOK 😳
Viral X/Twitter content with 2,500,000 views
Read more →GLP-1 side effects are REAL and nobody talks about them 😅
Viral X/Twitter content with 1,800,000 views
Read more →Working mom loses 71lbs with GLP-1 while raising 4 kids 🔥
Viral X/Twitter content with 3,200,000 views
Read more →Ready to start your GLP-1 journey?
Gila helps you build lasting habits, understand your body, and stay on track. Join the pilot for free.
Join the Pilot